Mao, Shuyan
Diao, Changying
Cao, Lei
Article History
Received: 29 April 2022
Revised: 22 August 2022
Accepted: 15 September 2022
First Online: 5 October 2022
Declarations
:
: The study was approved by the Medical Ethics Committee of Shanghai Pudong New Area People’s Hospital, China, and the Medical Ethics Committee granted an exempt from signing written informed consent. Because this study only reported a rare case, and was not an intervening trial and the follow-up was not involved, there was little risk for the patient in this study.
: The patient has died, and we have obtained the oral consent the relatives of the patient.
: The authors declare that they have no competing interests.